← Browse by Condition
Medical Condition
sle systemic lupus
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1
NCT06613360 Phase 1
Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
Enrollment
24 pts
Location
United States, Austr...
Sponsor
Cullinan Therapeutics Inc.
NCT07237659 Phase 1
Recruiting
Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
Enrollment
48 pts
Location
United States
Sponsor
Neutrolis